The ABCs of viral hepatitis. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


The ABCs of viral hepatitis. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

Common Factor. 1995 Apr;(no 10):10-2. Unique Identifier : AIDSLINE AIDS/95700365
Haas GJ

Abstract: A short introduction to each of the known hepatitis viruses is provided, along with brief information about the transmission, associated disease progression, and treatment of each virus. All of the different hepatitis viruses in existence have the common factor of infecting the liver cells. These viruses can infect other cells as well. Evidence exists of several new hepatitis viruses that have yet to be properly identified. The existence of these new viruses provides still more reason for blood and blood products to be virally inactivated for as broad a spectrum of viruses as possible. The hemophilia community was not aware of the serious risks that existed from hepatitis-infected blood products, so little pressure was applied to the blood banks and blood fractionators to screen out blood drawn from infected persons or those with signs of liver disease. Some known viruses are still not screened for, and methods to more completely eradicate viruses from blood and blood products are not yet implemented; treatment for hepatitis and liver disease remains inadequate.
Keywords: Antibodies, Viral/BLOOD Antigens, Viral/BLOOD Hepatitis Viruses/IMMUNOLOGY/ISOLATION & PURIF/PATHOGENICITY Hepatitis, Toxic Hepatitis, Viral, Human/TRANSMISSION/*VIROLOGY Human Species Specificity NEWSLETTER ARTICLE

KWDantibodies,viral/bloodantigens,viral/bloodhepatitisviruses/immunology/isolation&purif/pathogenicityhepatitis,toxichepatitis,viral,human/transmission/KWDvirologyhumanspeciesspecificitynewsletterarticle
951130
M95B0900

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .